Press release
Compounding Pharmacies Market to Hit US$ 14,995.1 million by 2028
Compounding pharmacies or compound pharmacy role is to mix ingredients as per patients' needs and manufacture drugs that are not commercially available. Pharmacy compounding has been present since the beginning of time. It is essential in cases such as limited dosage strengths and dosage forms, drug allergies to certain ingredients, pediatrics, chemotherapy and veterinary medicine. Further, compounded medicines enhance pharmacist contribution to developing and implementing patient therapeutic plans and provide customized medications of high pharmaceutical quality.The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 6.1% from 2021 to 2028.
Get Sample Copy with Complete TOC and Figures & Graphs @ https://www.theinsightpartners.com/sample/TIPRE00005407/?utm_source=OpenPR&utm_medium=10357
Market leaders operating in the market have undertaken various organic growth strategies in the compounding pharmacies market. The compounding pharmacies market majorly consists of the players Fagron, Inc., Elixir Compounding Pharmacy, Avella specialty pharmacy, B. Braun Melsungen AG, PharMEDium Healthcare Holdings, Inc., Fresenius Kabi AG, Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy and US Compounding Inc. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaborations.
Pain Medications Segment to be Largest Contributor to Compounding Pharmacies Market During 2021-2028
Based on therapeutic area, the compounding pharmacies market is segmented into pain medications, hormone replacement therapies, dermatological applications, and others. The pain medications segment held the largest share of the market in 2020 and the same segment is estimated to register the highest CAGR in the market during the forecast period.
Purchase a Copy of this Report: https://www.theinsightpartners.com/buy/TIPRE00005407/?utm_source=OpenPR&utm_medium=10357
About Us:
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, chemicals etc.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Compounding Pharmacies Market to Hit US$ 14,995.1 million by 2028 here
News-ID: 2830654 • Views: …
More Releases from The Insight Partners
Navigating the Future: Portable Ultrasound Devices Market Report Unveiled
The Insight Partners is proud to announce its newest market report, "Portable Ultrasound Devices Market: An In-depth Analysis of the Portable Ultrasound Devices Market". The report provides a holistic view of the Portable Ultrasound Devices Market and describes the current scenario as well as growth estimates of Portable Ultrasound Devices during the forecast period.
👉 Download the Report Here: https://www.theinsightpartners.com/sample/TIPRE00019280/?utm_source=OpenPR&utm_medium=10129
The Portable Ultrasound Devices Market has experienced steady growth driven by demand…
Female Pelvic Implant Market to Reach US$ 268.84 Million by 2031 - Expected CAGR …
United States of America - December 15, 2025 - According to The Insight Partners, The Female Pelvic Implant Market size is expected to reach US$ 268.84 Million by 2031. The market is anticipated to register a CAGR of 4.0% during 2025-2031. The Female Pelvic Implant Market is quietly shifting from a niche clinical specialty into a more mainstream segment of women's health care. At its heart are solutions for pelvic…
Disc Spring Market Poised for Robust Growth as Industries Demand High-Performanc …
The latest study on the Disc Spring Market, published by The Insight Partners, highlights a strong growth outlook over the next decade, supported by rising industrial automation, stringent performance requirements, and the need for reliable load management in constrained spaces. The report covers key segments such as disc spring thickness, type, application, and end-use industry, providing a holistic view of the evolving market landscape.
Disc springs, also known as Belleville springs…
Currency Counting Machine Market to Witness Steady Growth Through 2031 Amid Risi …
The Insight Partners has released its latest research report on the Currency Counting Machine Market, highlighting steady expansion during the forecast period from 2025 to 2031.
The report delivers a comprehensive assessment of the market segmented by Types, Technology, and Application, along with detailed global, regional, and country-level analysis. Market size estimates and forecasts are presented in USD for all key segments, offering valuable insights into current trends, growth drivers,…
More Releases for Compounding
Compounding Pharmacies Business Development Strategies for Expanding Your Market …
The global compounding pharmacies market size was US$ 8.1 billion in 2021. The global compounding pharmacies market size is estimated to reach US$ 13.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2022 to 2030.
Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=bwcc17220
A compounding pharmacy is a distinctive kind of pharmacy. They can create customized medicines for the individual who…
NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of…
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global…
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc.
Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured…
